Previous close | 127.70 |
Open | 127.30 |
Bid | 123.80 x 0 |
Ask | 124.00 x 0 |
Day's range | 123.40 - 128.00 |
52-week range | 111.60 - 134.50 |
Volume | |
Avg. volume | 113,172 |
Market cap | 29.078B |
Beta (5Y monthly) | 0.14 |
PE ratio (TTM) | 44.29 |
EPS (TTM) | 2.80 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 5.12 (4.01%) |
Ex-dividend date | 17 Apr 2024 |
1y target est | 129.56 |
KRYAY vs. NSRGY: Which Stock Is the Better Value Option?
JPMorgan has turned positive on Unilever (LON:ULVR), after several years of caution, but has taken a more cautious view on Nestle (SIX:NESN) as its earnings growth moderates. Unilever has instituted several changes over the past 12 months, analysts at JPMorgan said in a note dated May 23, which have soothed the bank’s concerns, including cultural change and corporate governance; market share underperformance through increased investments and execution focus; and portfolio transformation with disposals. This feeds a stronger FY24, and should give credence to Unilever is on the path to turnaround and contribute to the stock re-rating along with positive earnings revision.
Weight loss drugs are rising in popularity, and food companies are cooking up new ways to win over those consumers.